FDA
-
-
-
-
-
-
-
Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
-
-
-
-
-
-
-
Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek
-
-
-
-
-
-
-
Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update
-
-
-
-
-
-
-
Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024
-
-
-
-
-
-
-
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
-
-
-
-
-
-
-
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
-
-
-
-
-
-
-
Spero Therapeutics to Present at Upcoming November Investor Conferences
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

